Salesforce: Buy Into the AI Selloff at 20x Earnings

Salesforce is a Buy. The stock has been battered down roughly 27% year-to-date after the broader "SaaSpocalypse" selloff and persistent doubts about whether its Agentforce AI push is real demand or management narrative. I think the multiple has compressed faster than the business has deteriorated. At roughly 20 times trailing earnings and 4.3 times EV/sales, CRM trades like a slowing enterprise software company instead of a cash-flow-generating platform that just crossed $1 billion in annualized AI revenue. Q2 fiscal 2027 earnings, expected around September 2, will be the next proof point - and the setup here is patience with a bullish skew.

Here is what changed. Salesforce's Q1 FY27 quarter, reported May 27, delivered $11.13 billion in revenue, up 13% year-over-year and ahead of consensus. Adjusted EPS of $3.88 beat the $3.13 estimate by a meaningful margin. Non-GAAP operating margin expanded to 34.8%, up 250 basis points from a year ago. More importantly, Agentforce ARR passed $1.2 billion for the first time, up 205% year-over-year. Combined with Data 360 and Informatica Cloud, Salesforce's AI and data ARR now totals $3.4 billion. Customers processed 28.6 trillion tokens and generated 3.8 billion Agentic Work Units, with AWUs growing 111% quarter-over-quarter. More than half of Agentforce and Data 360 bookings came from existing customers. This is not a narrative patch. This is revenue.

The weak spots matter too. Tableau and Commerce showed clear deceleration, and parts of the marketing business remain soft. Remaining performance obligations came in at $67.9 billion versus Street consensus of $68.6 billion, so backlog growth disappointed. And management acknowledged the integration lift from a string of acquisitions: Informatica ($9.6 billion last November), Qualified, Cimulate, Momentum, and now Fin (formerly Intercom) for approximately $3.6 billion, announced in June. That is a lot to execute on.

The valuation, however, is where the argument crystallizes. CRM trades at approximately 19.7x trailing earnings and 23x forward earnings, with an EV/EBITDA multiple of 13.1x and a forward EV/Sales of 4.3x. Compare that with ServiceNow at 72.6x earnings and 44.3x EV/EBITDA, or Oracle at 24.5x earnings and 17.2x EV/EBITDA. Salesforce is generating far superior cash conversion - free cash flow was $6.6 billion in Q1 alone, and the trailing twelve-month FCF margin sits at 34.2%. The $14.7 billion in TTM free cash flow funds a $25 billion accelerated share repurchase program while still leaving $8.9 billion in cash on the balance sheet against $72.4 billion in total debt. Net leverage is elevated but manageable for this cash-flow profile. The market is pricing Salesforce as if AI is vaporware and growth is structurally broken. The numbers do not support that conclusion.

The catalyst clock is set. Q2 FY27 earnings around September 2 will test whether Agentforce momentum continues, whether Tableau and Commerce weakness stabilizes, and whether the Fin acquisition rationale starts to show in bookings. Management guided Q2 revenue to $11.27-$11.35 billion (10-11% growth) and full-year FY27 revenue to $45.9-$46.2 billion (~11% growth), with organic acceleration expected in H2. If Q2 revenue lands at the midpoint and Agentforce ARR continues its parabolic trajectory, the multiple should begin to re-expand from current depressed levels.

Risks:

• Tableau and Commerce deceleration persists. These segments have been soft and could widen if enterprise budgets tighten further.
• Acquisition integration risk. Four new names in one fiscal year (Qualified, Cimulate, Momentum, Fin) create execution overhead and margin drag potential.
• AI adoption skepticism remains. Analysts such as Bank of America... have questioned whether Agentforce bookings translate to durable usage. The usage metrics (tokens, AWUs) are impressive but proprietary - they cannot be independently audited.
• Revenue growth normalizing. The shift from 20%+ historical growth to the low-double-digit range means the market will no longer reward multiple expansion absent clear reacceleration.

Investor takeaway: Salesforce is a Buy at current levels. The 27% YTD selloff has priced in structural AI disruption and permanent growth deceleration that the fundamentals do not justify. Agentforce ARR above $1.2 billion, FCF margins above 34%, and a trailing P/E near 20x create an asymmetric risk/reward for patient investors. The case upgrades to a stronger conviction Buy if Q2 confirms continued Agentforce momentum and RPO reacceleration. It downgrades to a Hold if Tableau/Commerce weakness accelerates, Agentforce usage data disappoints, or H2 guidance gets cut. The September 2 earnings report will separate narrative from evidence - and the multiple today is cheap enough to tolerate execution missteps.